cyanides has been researched along with B-Cell Chronic Lymphocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binderup, L; Björkling, F; Ekelund, S; Larsson, R; Liminga, G; Ottosen, E; Schou, C | 1 |
| Binderup, L; Friberg, LE; Hassan, SB; Jonsson, E; Karlsson, MO; Kristensen, J; Larsson, R; Nygren, P; Tholander, B | 1 |
| de la Torre, M; Hassan, SB; Jonsson, E; Karlsson, MO; Larsson, R; Nygren, P | 1 |
3 other study(ies) available for cyanides and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: comparison with m-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Cyanides; DNA, Neoplasm; Fluorometry; Guanidines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Proteins; Tumor Cells, Cultured | 2000 |
In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Division; Cyanides; Cytological Techniques; Female; Guanidines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Ovarian Neoplasms; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cyanides; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Guanidines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Ovarian Neoplasms; Tumor Cells, Cultured | 2001 |